Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Innovative DNA technology speeds up TB diagnosis
DNA
Whole Genome Sequencing is a faster, cheaper and more effective way of diagnosing TB.

Whole Genome Sequencing found to be more effective

Scientists are using innovative DNA technology to diagnose cases of TB up to eight times faster than traditional methods.

A study led by the University of Oxford concludes that Whole Genome Sequencing is a faster, cheaper and more effective way of diagnosing TB.

The researchers say that the method marks 'a significant milestone' in the way TB is tackled, but the outlook looks even better, as whole genome sequencing technology is set to improve.

Whole Genome Sequencing has been used before in TB research studies, but this is the first time that it has been applied in real world scenarios.

In the study, the researchers were able to detect presence of TB and whether it was resistant to commonly used antibiotics within one week - up to eight times faster than utilising traditional diagnosis methods. 

Furthermore, the fast diagnosis meant the scientists were able to detect and respond to potential outbreaks as they happen.

The method has also proven to be more cost-effective, at an average of £481 per positive case, compared to £517 per case using current technologies.

Lead author Dr Louise Pankhurst from the University of Oxford, said: "This is a really exciting time to be working in infectious disease research. The UK is poised to become the first country in the world to replace traditional tuberculosis diagnosis with whole genome sequencing.

"Our study has shown how this will dramatically speed up the time taken to diagnose TB, helping patients be placed on the most effective treatment as soon as possible and reducing the risk of disease transmission."

The research, Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study is published in the Lancet Respiratory Medicine.

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk